United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - ferrous fumarate - oral tablet - 322mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - ferrous fumarate - oral tablet - 210mg

United States - English - NLM (National Library of Medicine)

puretek corporation - cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) - iron 53 mg - purevit dualfe plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. purevit dualfe plus is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - folic acid, quantity: 0.35 mg; ferrous fumarate, quantity: 310 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; titanium dioxide; iron oxide red; microcrystalline cellulose; purified talc; sodium starch glycollate type a; hypromellose; magnesium stearate; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the prevention and treatment of these conditions during pregnancy.

Canada - English - Health Canada

schein pharmaceutical canada inc. - iron (ferrous fumarate) - capsule - 100mg - iron (ferrous fumarate) 100mg - iron preparations

New Zealand - English - Medsafe (Medicines Safety Authority)

neo pharma limited - ferrous fumarate 200mg equivalent to elemental iron 65.7mg - film coated tablet - 200 mg - active: ferrous fumarate 200mg equivalent to elemental iron 65.7mg excipient: colloidal silicon dioxide hypromellose iron oxide black iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose povidone purified talc sodium starch glycolate titanium dioxide triethyl citrate - source of iron for the treatment and prevention of iron deficiency and iron deficiency anaemia.